fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells pharma, NDC 73702-202-15.
Recall Number: D-0508-2026
Firm: Wells Pharma of Houston LLC
Classification: Class II
Status: Ongoing
Report Date: 20260506
Initiation Date: 20260401
Termination Date:
Reason for Recall
cGMP deviations.
Product Description
fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells pharma, NDC 73702-202-15.